(Q40951753)

25 September 2017

Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines (English)

1 reference

25 September 2017

0 references

1 reference

1 reference

Yano H

1

1 reference

25 September 2017

Iemura A

2

1 reference

25 September 2017

Haramaki M

3

1 reference

25 September 2017

Ogasawara S

4

1 reference

25 September 2017

Takayama A

5

1 reference

25 September 2017

Akiba J

6

1 reference

25 September 2017

Kojiro M

7

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 June 1999

1 reference

25 September 2017

1 reference

25 September 2017

29

1 reference

25 September 2017

1708-1717

1 reference

25 September 2017

6

1 reference

describes a project that uses

25 September 2017

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

Interferons and their actions

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Cloning and expression of a long form of the beta subunit of the interferon alpha beta receptor that is required for signaling

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Mutant U5A cells are complemented by an interferon-alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

The human interferon alpha/beta receptor: characterization and molecular cloning

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Transcriptional responses to polypeptide ligands: the JAK-STAT pathway

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Jaks and Stats in signaling by the cytokine receptor superfamily

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Specific depletion of the B-cell population induced by aberrant expression of human interferon regulatory factor 1 gene in transgenic mice.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Cytokine therapeutics: lessons from interferon alpha

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Quantitative analysis of interferon alpha/beta receptor mRNA in the liver of patients with chronic hepatitis C: correlation with serum hepatitis C virus-RNA levels and response to treatment with interferon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Effectiveness of interferon-alpha therapy in chronic hepatitis C is associated with the amount of interferon-alpha receptor mRNA in the liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Recombinant interferon-α in inoperable hepatocellular carcinoma: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Treatment of hepatocellular carcinoma with recombinant leucocyte interferon: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

A prospective trial of recombinant human interferon alpha 2B in previously untreated patients with hepatocellular carcinoma. The Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Interferons and interleukin-6 suppress the DNA-binding activity of E2F in growth-sensitive hematopoietic cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Role of G0-G1 arrest in the inhibition of tumor cell growth by interferon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Interferon-beta induces S phase accumulation selectively in human transformed cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Flow cytometric analysis of antineoplastic effects of interferon-alpha, beta and gamma labelled with fluorescein isothiocyanate on cultured brain tumors.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Interferon affects both G1 and S+G2 in cells stimulated from quiescence to growth

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Interferon suppresses the transition of quiescent 3T3 cells to a growing state

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1/Fas)-CD95 ligand-induced suicide

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Induction of apoptotic cell death in non-melanoma skin cancer by interferon-alpha

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Human lymphoblastoid interferon. In vitro and in vivo studies in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

A new human hepatocellular carcinoma cell line (KYN-1) with a transformation to adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Establishment of two distinct human hepatocellular carcinoma cell lines from a single nodule showing clonal dedifferentiation of cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Establishment and characterization of a human combined hepatocholangiocarcinoma cell line and its heterologous transplantation in nude mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

A human combined hepatocellular and cholangiocarcinoma cell line (KMCH-2) that shows the features of hepatocellular carcinoma or cholangiocarcinoma under different growth conditions

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Expression of Fas and anti-Fas-mediated apoptosis in human hepatocellular carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Soluble interferon-alpha receptor molecules are present in body fluids

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Interferon-alpha-mediated prevention of in vitro apoptosis of chronic lymphocytic leukemia B cells: role of bcl-2 and c-myc

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Interferon-alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

The Bcl-2 protein family: arbiters of cell survival

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Interferon alpha induces the expression of retinoblastoma gene product in human Burkitt lymphoma Daudi cells: role in growth regulation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Induction of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-alpha in hematopoietic cell lines

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

A role for the cyclin-dependent kinase inhibitor p21 in the G1 cell cycle arrest mediated by the type I interferons

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Interferon-alpha inhibits cyclin E- and cyclin D1-dependent CDK-2 kinase activity associated with RB protein and E2F in Daudi cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

IFNalpha induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290624

7 January 2021

Identifiers

DOI

10.1002/HEP.510290624

1 reference

25 September 2017

1 reference